Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Cadila Healthcare informs about press release

30 Dec 2017

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Valacyclovir Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

655.20 -9.80 (-1.47%) Jun 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 677.25
Dr. Reddys Lab 5459.55
Lupin 1192.60
Piramal Enterprises 2220.70
Cadila Healthcare 655.20
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback